重症医学随机对照试验发表于高影响因子期刊的多变量预测模型:SCOTI评分
该研究基于1999年至2018年发表于三大高影响综合医学期刊(NEJM、The Lancet、JAMA)或三大高影响重症期刊(ICM、AJRCCM、CCM)的968项重症RCT,拆分为推导队列(n=510)和验证队列(n=458),开发并内部验证预测RCT发表于高影响综合期刊的简化评分。推导队列中,样本量(P值<0.001)、参与中心数(P值=0.01)、以死亡率为主要结局(P值=0.002)或包含死亡率的复合主要结局(P值=0.004)、主题为通气(P值<0.001)或其他(P值<0.001)是独立预测因素。SCOTI评分在拆分样本验证中AUC为0.84(95%CI 0.80-0.88)。该评分可用于投稿前评估RCT发表于高影响综合期刊的概率。
要点
- SCOTI评分由样本量、中心数、结局、主题和国际评分构成,验证AUC 0.84(95%CI 0.80-0.88)。
- 推导队列中样本量(P值<0.001)、中心数(P值=0.01)与发表于高影响综合期刊独立相关。
- 以死亡率为主要结局(P值=0.002)或含死亡率的复合结局(P值=0.004)是独立预测因素。
- 主题为通气(P值<0.001)或其他(P值<0.001)与发表于高影响综合期刊独立相关。
- 研究目的为投稿前评估正在进行的试验有无机会发表于高影响综合期刊。
适用人群与场景
- 1999年至2018年发表于NEJM、The Lancet、JAMA或ICM、AJRCCM、CCM的重症医学随机对照试验,共968项,拆分为推导队列(n=510)和验证队列(n=458)。
研究设计与关键结果
- 研究类型为队列研究,共纳入968项重症RCT,拆分为推导队列(n=510)和验证队列(n=458)。
- 主要结局为发表期刊类别:高影响综合期刊(NEJM、The Lancet、JAMA)或高影响重症期刊(ICM、AJRCCM、CCM)。
- 推导队列中,样本量(P值<0.001)、参与中心数(P值=0.01)、以死亡率为主要结局(P值=0.002)或包含死亡率的复合主要结局(P值=0.004)、主题为通气(P值<0.001)或其他(P值<0.001)是发表于高影响综合期刊(相比高影响重症期刊)的独立预测因素。
- SCOTI评分(样本量、中心数、结局、主题和国际评分)在拆分样本验证中AUC为0.84(95%CI 0.80-0.88)。
证据类型、等级与局限
- 证据类型:队列研究(推导与拆分样本内部验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- SCOTI评分可用于投稿前预测正在进行的重症RCT发表于高影响综合期刊(相比高影响重症期刊)的概率,AUC为0.84(95%CI 0.80-0.88)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Critical care randomized controlled trials (RCTs) are often published in high-impact journals, whether general journals [the New England Journal of Medicine (NEJM), The Lancet, the Journal of the American Medical Association (JAMA)] or critical care journals [Intensive Care Medicine (ICM), the American Journal of Respiratory and Critical Care Medicine (AJRCCM), Critical Care Medicine (CCM)]. As rejection occurs in up to 97% of cases, it might be appropriate to assess pre-submission probability of being published. The objective of this study was to develop and internally validate a simplified score predicting whether an ongoing trial stands a chance of being published in high-impact general journals.
METHODS: A cohort of critical care RCTs published between 1999 and 2018 in the three highest impact medical journals (NEJM, The Lancet, JAMA) or the three highest impact critical care journals (ICM, AJRCCM, CCM) was split into two samples (derivation cohort, validation cohort) to develop and internally validate the simplified score. Primary outcome was journal of publication assessed as high-impact general journal (NEJM, The Lancet, JAMA) or critical care journal (ICM, AJRCCM, CCM).
RESULTS: A total of 968 critical care RCTs were included in the predictive cohort and split into a derivation cohort (n = 510) and a validation cohort (n = 458). In the derivation cohort, the sample size (P value < 0.001), the number of centers involved (P value = 0.01), mortality as primary outcome (P value = 0.002) or a composite item including mortality as primary outcome (P value = 0.004), and topic [ventilation (P value < 0.001) or miscellaneous (P value < 0.001)] were independent factors predictive of publication in high-impact general journals, compared to high-impact critical care journals. The SCOTI score (Sample size, Centers, Outcome, Topic, and International score) was developed with an area under the ROC curve of 0.84 (95% Confidence Interval, 0.80-0.88) in validation by split sample.
CONCLUSIONS: The SCOTI score, developed and validated by split sample, accurately predicts the chances of a critical care RCT being published in high-impact general journals, compared to high-impact critical care journals.
参考来源
- Pensier J, De Jong A, Chanques G, et al. A multivariate model for successful publication of intensive care medicine randomized controlled trials in the highest impact factor journals: the SCOTI score. Ann Intensive Care. 2021. PMID: 34837580. doi:10.1186/s13613-021-00954-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。